A Purdue University researcher has developed a novel strategy on identifying antimicrobial drugs to better treat bacterial and fungal infections, which could produce significant impacts that leapfrog the drug development ...
Mar 10, 2016
0
5
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs"—infections that increasingly don't respond to drugs and threaten millions of people in countries rich ...
Jan 21, 2016
0
56
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference ...
Sep 21, 2015
0
3
The global pharmaceutical industry should set up a $2.0 billion (1.8-billion euro) global innovation fund to help kickstart research into developing more resistant antibiotics, experts said on Thursday.
May 14, 2015
0
7
Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread ...
Apr 28, 2015
1
679
A major problem with current testing for infectious diseases in Africa is that it focuses on individual diseases and cannot reliably discriminate between them. Since most infectious diseases have the same feverish symptoms, ...
Mar 27, 2015
0
16
In the first installment of a new series, Peter Doshi, Assistant Professor at the University of Maryland School of Pharmacy and Associate Editor at The BMJ, asks why authorities are approving drugs with little evidence they ...
Mar 26, 2015
0
5
Treatment options for some of the most common food-borne infections are decreasing, as types of bacteria (called 'isolates') continue to show resistance to antimicrobial drugs. For example, multi-drug resistant isolates of ...
Feb 28, 2015
0
24
A British government-commissioned review has found that resistance to antibiotics could account for 10 million deaths a year and hit global gross domestic product by 2.0 to 3.5 percent by 2050.
Dec 15, 2014
0
0
A treatment pioneered at the University of Pittsburgh Center for Vaccine Research (CVR) is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called "superbugs" ...
Dec 10, 2014
0
0
